Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H25ClFN3O2 |
Molecular Weight | 416.907 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)CC1=C(N=C2C=CC(Cl)=CN12)C3=CC=C(OCCC[18F])C=C3
InChI
InChIKey=YFXIZOLPHFYYMF-MIGPCILRSA-N
InChI=1S/C22H25ClFN3O2/c1-3-26(4-2)21(28)14-19-22(25-20-11-8-17(23)15-27(19)20)16-6-9-18(10-7-16)29-13-5-12-24/h6-11,15H,3-5,12-14H2,1-2H3/i24-1
Molecular Formula | C22H25ClFN3O2 |
Molecular Weight | 416.907 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:54:25 UTC 2023
by
admin
on
Sat Dec 16 09:54:25 UTC 2023
|
Record UNII |
3W97GXI2IU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1009080-75-4
Created by
admin on Sat Dec 16 09:54:25 UTC 2023 , Edited by admin on Sat Dec 16 09:54:25 UTC 2023
|
PRIMARY | |||
|
24944913
Created by
admin on Sat Dec 16 09:54:25 UTC 2023 , Edited by admin on Sat Dec 16 09:54:25 UTC 2023
|
PRIMARY | |||
|
3W97GXI2IU
Created by
admin on Sat Dec 16 09:54:25 UTC 2023 , Edited by admin on Sat Dec 16 09:54:25 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->RADIOLIGAND |
PET with radioligands targeting the TSPO can detect patterns of neuroinflammation in vivo. Monitoring activated microglia is of great interest to assess disease severity and progressionas well as therapeutic efficacy of anti-inflammatory drugs. Several recent lines of evidence support that neuroinflammation plays an important role in schizophrenia.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|